While only two therapies have so far gained approval, the broader pipeline paints a picture of strong research and ...

Tylenol’s label change plus leucovorin's approval offer a taster to the Trump administration’s plans to crack down on the US ...

This is the second therapy available, expanding options beyond surgery and the limited use of interferon marketed in Russia.

Eli Lilly and Novo Nordisk are in a tight race to capture the lucrative oral obesity drug market – but how will their ...

On 17 September, at the European Association for the Study of Diabetes (EASD) event in Vienna, findings were presented from a ...

The Gates Foundation has outlaid $912m to prevent global deaths from infectious diseases such as AIDS, tuberculosis, and ...

China rising to the top in the CGT space, the future of promising cancer vaccines in light of Trump admin's mRNA distancing, ...

While tools from digital therapeutics to neuromodulation headsets to address mental health conditions are being developed, ...

Metsera, which went public in January this year, could provide Pfizer with strong growth drivers in the obesity treatment ...

Merck and Siemens have extended their strategic partnership, aimed at accelerating digital transformation in the life sciences sector.

Astellas Pharma has received conditional approval in Japan for Izervay to suppress geographic atrophy (GA) growth.

The withdrawal of a series of high-profile investments over the past few days has sent the strongest signal to the government ...